Literature DB >> 8750038

Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.

C H Lammers1, D Garcia-Borreguero, J Schmider, U Gotthardt, M Dettling, F Holsboer, I J Heuser.   

Abstract

Hypothalamic-pituitary-adrenal system (HPA) function was tested in 24 patients with schizophrenia and compared to 24 age-matched healthy volunteers using the combined dexamethasone-suppression (DST/CRH) corticotropin-releasing hormone stimulation test (DST/CRH). After stimulation with CRH, the dexamethasone-pretreated patients released significantly more cortisol, but a similar amount of adrenocorticotropic hormone (ACTH) in comparison to controls. No association between DST status and degree of severity of illness and/or current medication was found. However, in comparison to unmedicated patients, those patients currently receiving antipsychotics, who were also those with a lesser degree of severity of illness, showed a decreased release of CRH-stimulated cortisol and ACTH. This study demonstrates that schizophrenic patients have a dysregulation of the HPA system as assessed with the DEX/CRH test. Overall, however, the degree of HPA-system dysfunction in schizophrenic patients seems to be of a lesser magnitude than in patients with affective disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8750038     DOI: 10.1016/0006-3223(95)00065-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  14 in total

1.  Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness.

Authors:  Duncan Sinclair; Shan Yuan Tsai; Heng Giap Woon; Cynthia Shannon Weickert
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

2.  Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia.

Authors:  H Karlsson; S Bachmann; J Schröder; J McArthur; E F Torrey; R H Yolken
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

3.  Ziprasidone decreases cortisol excretion in healthy subjects.

Authors:  Andreas Meier; Anna-Catharina Neumann; Wolfgang Jordan; Gerald Huether; Andrea Rodenbeck; Eckart Rüther; Stefan Cohrs
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

4.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

5.  Human endogenous retroviruses with transcriptional potential in the brain.

Authors:  Akifumi Nakamura; Yuji Okazaki; Jun Sugimoto; Takaya Oda; Yoshihiro Jinno
Journal:  J Hum Genet       Date:  2003-10-15       Impact factor: 3.172

6.  Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects.

Authors:  Stefan Cohrs; Kathrin Pohlmann; Zhenghua Guan; Wolfgang Jordan; Andreas Meier; Gerald Huether; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

7.  Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.

Authors:  Victoria B Risbrough; Richard L Hauger; Amanda L Roberts; Wylie W Vale; Mark A Geyer
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

8.  Cognitive modulation of endocrine responses to CRH stimulation in healthy subjects.

Authors:  James L Abelson; Samir Khan; Elizabeth A Young; Israel Liberzon
Journal:  Psychoneuroendocrinology       Date:  2009-09-16       Impact factor: 4.905

9.  Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment.

Authors:  Valeria Mondelli; Paola Dazzan; Nilay Hepgul; Marta Di Forti; Monica Aas; Alessandro D'Albenzio; Marco Di Nicola; Helen Fisher; Rowena Handley; Tiago Reis Marques; Craig Morgan; Serena Navari; Heather Taylor; Andrew Papadopoulos; Katherine J Aitchison; Robin M Murray; Carmine M Pariante
Journal:  Schizophr Res       Date:  2009-09-13       Impact factor: 4.939

10.  Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy.

Authors:  Astrid Zobel; Jörg Wellmer; Svenja Schulze-Rauschenbach; Ute Pfeiffer; Susanne Schnell; Christian Elger; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.